From clinical trials and marketed use overdoses have been reported up to 40 times (72mg) the recommended maintenance dose (72 mg). Generally the patient reported severe nausea, vomiting and diarrhoea. None of the reports included severe hypoglycaemia. All patients recovered without complications.
In the event of overdose, appropriate supportive treatment should be initiated according to the patient's clinical signs and symptoms.